Plant Comparison
Greater Burdock vs Bitter Melon
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Greater Burdock and Bitter Melon: they share 6 indicated uses (arthritis / joint pain, bloating, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Greater Burdock | Bitter Melon | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 5/10 | Stronger for Bitter Melon |
| Bloating | 2/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 9/10 | Stronger for Bitter Melon |
| Indigestion | 2/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 1/10 | Comparable evidence |
| Skin irritation | 2/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Burdock root is a rich source of prebiotic inulin-type fructans (fructooligosaccharides) along with chlorogenic and caffeic acids, the lignans arctiin and arctigenin, cynarine and quercetin, which underlie its antioxidant, anti-inflammatory and gut-supporting activity.
Now regarded as the main antidiabetic principles.
A mixture of two sterol glucosides, historically credited with the hypoglycaemic effect.
An insulin-like polypeptide of the fruit and seed.
A pyrimidine glycoside that can trigger favism in G6PD-deficient people.
Pharmacological Actions
Burdock (Arctium lappa) extracts and the lignan arctigenin inhibit proliferation and induce apoptosis in colon, breast, lung and gastric cancer cells, attenuate melanoma progression and reduce preneoplastic colon lesions in vivo (preclinical).
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from digestive action
Arctium lappa root reduces diet-induced preneoplastic colon lesions and suppresses melanoma progression; its lignan arctigenin induces apoptosis in colon (HT-29), breast (in vitro/in vivo), lung and gastric cancer cells and chemosensitizes them to doxorubicin (preclinical).
inferred from digestive action
inferred from anti-inflammatory action
inferred from bitter-tonic action
inferred from anti-inflammatory action
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally safe as a food plant. Allergic reactions are possible in those sensitive to Asteraceae. Avoid in pregnancy due to uterine-stimulating effects reported in animal studies. The burs (seed heads) can cause mechanical irritation of skin and eyes on contact. Not recommended in biliary obstruction.
Duke (2002) rates burdock as +++ and notes antibacterial, antimutagenic, antitumor, choleretic, diuretic, and prebiotic (bifidogenic) activities at the experimental level (score 1). The root is rich in inulin (a prebiotic fructooligosaccharide), which promotes growth of beneficial intestinal bacteria. Dose: 1–2 g dried root in tea three times daily, or 2–4 ml of tincture. Duke notes burdock's general safety, though it belongs to the Asteraceae family and can trigger reactions in sensitive individuals. It should be distinguished from belladonna and similar plants, which resemble it in early growth (Duke, 2002).
Avoid in pregnancy: bitter melon can stimulate the uterus and has been associated with miscarriage; also avoid during breastfeeding.
Strong blood-sugar-lowering action: used with insulin or other diabetes medicines it can cause hypoglycaemia - monitor blood glucose and seek medical advice.
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid the seeds, which contain vicine and can cause favism (haemolytic anaemia). Excessive intake may cause abdominal pain and diarrhoea.
External Ids
Botanical Description
Robust biennial herb forming a large rosette of huge, heart-shaped (rhubarb-like), long-stalked leaves, dark green above and whitish-woolly beneath, in its first year. In the second year it sends up a tall, branching, grooved flowering stem bearing purple thistle-like flower heads enclosed in a globe of stiff, hooked bracts that ripen into the familiar clinging burrs.[1, 2]
Climbing or trailing annual vine (Cucurbitaceae) that climbs by simple tendrils, typically 2-5 m long. Leaves are alternate, long-stalked and palmately lobed with 5-7 deep, toothed lobes. Flowers are small, yellow and five-petalled, male and female flowers separate on the same plant. The fruit is an oblong, warty-skinned gourd that ripens from green to orange-yellow and splits open to reveal seeds coated in a bright red aril; the unripe green fruit is the part used medicinally and as food.
Habitat
A common weed of disturbed ground, waste places, roadsides, field margins and riverbanks on rich, moist soils; native to Europe and temperate Asia and naturalised in North America and elsewhere.[2]
Likely native to tropical Asia (possibly the Indian subcontinent), now widely cultivated across tropical and subtropical Asia, Africa, the Caribbean and increasingly the Americas as a vegetable and medicinal crop; needs warmth, full sun and a trellis or support to climb.[11]
Harvesting
The root is dug at the end of the first growing season (autumn) or early in the second spring, before the flowering stem develops, when it is at its most tender and richest in inulin; leaves are picked through the first year, and the seed/fruit is collected from the dried burrs in the second autumn. Careful identification against deadly nightshade, whose root can resemble burdock, is essential before digging.[11]
The fruit is harvested unripe, while still green and firm, before it yellows and splits, for use as a vegetable and in traditional antidiabetic preparations; leaves are also traditionally gathered.[11]
Traditional Uses
Bitter melon has a long history in Asian, African and Caribbean traditional medicine as a bitter digestive tonic and mild laxative, and most notably as a remedy for diabetes and its complications; this traditional antidiabetic use is now the most scientifically supported of its properties, with numerous studies on its blood-glucose- and lipid-lowering effects.[4, 11]
Preparations
Dried or fresh root simmered in water as a traditional alterative and digestive decoction.
Tincture of the dried root, ethanol 45% V/V or 25% V/V, 8-12 ml three times daily per the EU herbal monograph. The monograph states the ethanol strength but no drug-extract ratio, so no 1:5 ratio is claimed here. Educational reference only, not a prescription.
Fresh root peeled and cooked as a root vegetable (gobo), continuing the traditional food-medicine use.
Dosage
The EU herbal monograph on Arctium lappa L., radix gives, for adults and elderly, a single dose of 2-6 g of the comminuted root as an infusion, 3 times daily; a powdered herbal substance at 350 mg 3-5 times daily, a liquid extract at 2-8 mL 3 times daily and a soft extract at 0.2 g per dose (1-2 g daily) are also listed. Not recommended under 18 years, and a practitioner should be consulted if symptoms persist beyond 2 weeks. Educational reference only, not a prescription.
The EU herbal monograph gives 8-12 mL three times daily, for tinctures in either 45% V/V or 25% V/V ethanol, in adults and elderly. Educational reference only, not a prescription.
Clinical trials studying bitter melon for blood-sugar support have used standardised fruit extract or juice preparations taken daily over several weeks; dosing varies by product. Because it can lower blood glucose, monitor levels closely if combining with diabetes medication. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
Drug Class Interactions
Not documented
References & Sources
- Chan, Y.S., Cheng, L.N., Wu, J.H., Chan, E., Kwan, Y.W., Lee, S.M.Y., Leung, G.P.H., Yu, P.H.F. and Chan, S.W (2010) 'A review of the pharmacological effects of Arctium lappa (burdock)', Inflammopharmacology, 19(5), pp. 245--254. doi:10.1007/s10787-010-0062-4 Preclinical
https://doi.org/10.1007/s10787-010-0062-4 - de Souza, A.R.C., de Oliveira, T.L., Fontana, P.D., Carneiro, M.C., Corazza, M.L., de Messias Reason, I.J. and Bavia, L (2022) 'Phytochemicals and Biological Activities of Burdock (Arctium lappa L.) Extracts: A Review', Chemistry and Biodiversity, 19(11). doi:10.1002/cbdv.202200615 Preclinical
https://doi.org/10.1002/cbdv.202200615 - Yosri, N., Alsharif, S.M., Xiao, J., Musharraf, S.G., Zhao, C., Saeed, A., Gao, R., Said, N.S., Di Minno, A., Daglia, M., Guo, Z., Khalifa, S.A.M. and El-Seedi, H.R (2023) 'Arctium lappa (burdock): insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine', Biomedicine & Pharmacotherapy, 158, pp. 114104. doi:10.1016/j.biopha.2022.114104 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2022.114104 - Mondal, S.C. and Eun, J.B (2022) 'Mechanistic insights on burdock (Arctium lappa L.) extract effects on diabetes mellitus', Food Science and Biotechnology, 31(8), pp. 999--1008. doi:10.1007/s10068-022-01091-2 Preclinical
https://doi.org/10.1007/s10068-022-01091-2 - Shyam, M. and Sabina, E.P (2024) 'Harnessing the power of Arctium lappa root: a review of its pharmacological properties and therapeutic applications', Natural Products and Bioprospecting, 14(1), pp. 49. doi:10.1007/s13659-024-00466-8 Meta-analysis / review
https://doi.org/10.1007/s13659-024-00466-8 - Gao, Q., Yang, M. and Zuo, Z (2018) 'Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L', Acta Pharmacologica Sinica, 39(5), pp. 787-801. doi:10.1038/aps.2018.32 Traditional / reference
https://doi.org/10.1038/aps.2018.32 - Jin, X., Liu, S., Chen, S., Wang, L., Cui, Y., He, J., Fang, S., Li, J. and Chang, Y (2023) 'A systematic review on botany, ethnopharmacology, quality control, phytochemistry, pharmacology and toxicity of Arctium lappa L. fruit', Journal of Ethnopharmacology, 308, pp. 116223. doi:10.1016/j.jep.2023.116223 Meta-analysis / review
https://doi.org/10.1016/j.jep.2023.116223 - Shukla, S., Kakade, M., Cherian, S., Alagarasu, K. and Parashar, D (2024) 'Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication', Phytomedicine, 128, pp. 155491. doi:10.1016/j.phymed.2024.155491 Preclinical
https://doi.org/10.1016/j.phymed.2024.155491 - Nascimento, B.A.C., Gardinassi, L.G., Silveira, I.M.G., Gallucci, M.G., Tome, M.A., Oliveira, J.F.D., Moreira, M.R.A., Meirelles, A.F.G., Faccioli, L.H., Tefe-Silva, C. and Zoccal, K.F (2019) 'Arctium lappa extract suppresses inflammation and inhibits melanoma progression', Medicines, 6(3), pp. 81. doi:10.3390/medicines6030081 Preclinical
https://doi.org/10.3390/medicines6030081 - Lu, N., Wei, J., Gong, X., Tang, X., Zhang, X., Xiang, W., Liu, S., Luo, C. and Wang, X (2023) 'Preventive effect of Arctium lappa polysaccharides on acute lung injury through anti-inflammatory and antioxidant activities', Nutrients, 15(23), pp. 4946. doi:10.3390/nu15234946 Preclinical
https://doi.org/10.3390/nu15234946 - Moro, T.M.A. and Clerici, M.T.P.S (2020) 'Burdock (Arctium lappa L) roots as a source of inulin-type fructans and other bioactive compounds: Current knowledge and future perspectives for food and non-food applications', Food Research International. doi:10.1016/j.foodres.2020.109889 Preclinical
https://doi.org/10.1016/j.foodres.2020.109889 - European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Arctium lappa L., radix'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arctium-lappa-l-radix_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arctium-lappa-l-radix_en.pdf - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Xu, Z., Li, Y., Jiang, D. and Deng, L (2008) 'Arctium lappa L.: A review of its traditional uses, phytochemistry, and pharmacology', 121(2), pp. 167--184. Traditional / reference
https://scholar.google.com/scholar?q=Arctium%20lappa%20L.%3A%20A%20review%20of%20its%20traditional%20uses%2C%20phytochemistry%2C%20and%20pharmacology - Romualdo, G.R., Silva, E.D.A., Da Silva, T.C., Aloia, T.P.A., Nogueira, M.S., De Castro, I.A. and others (2019) 'Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis', Environmental Toxicology, 35(4), pp. 518--527. doi:10.1002/tox.22887 Preclinical
https://doi.org/10.1002/tox.22887 - Chen, Y.-F. and Liu, R.-Z. and Ying, W.-W. and Yang, Y.-N. and Xiang, S.-F. and Shao, X.-J. and Cao, J. and Zhang, Y.-Q. and Yang, B. and He, Q.-J. and Ying, M.-D (2022) 'Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells', Acta Pharmacologica Sinica, 44(3), pp. 661-669. doi:10.1038/s41401-022-00992-6 Preclinical
https://doi.org/10.1038/s41401-022-00992-6 - Shi, H. and Zhao, L. and Guo, X. and Fang, R. and Zhang, H. and Dong, G. and Fu, J. and Yan, F. and Zhang, J. and Ning, Z. and Ma, Q. and Li, Z. and Li, C. and Dai, J. and Si, C. and Xiong, H (2020) 'Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/beta-Catenin Signaling', International Journal of Molecular Sciences, 21(17), pp. 6357. doi:10.3390/ijms21176357 Preclinical
https://doi.org/10.3390/ijms21176357 - Li, Q.-C. and Liang, Y. and Tian, Y. and Hu, G.-R (2016) 'Arctigenin induces apoptosis in colon cancer cells through ROS/p38MAPK pathway', Journal of BUON, 21(1), pp. 87-94. Preclinical
https://scholar.google.com/scholar?q=Arctigenin%20induces%20apoptosis%20in%20colon%20cancer%20cells%20through%20ROS/p38MAPK%20pathway - Lee, K.-S. and Lee, M.-G. and Kwon, Y.-S. and Nam, K.-S (2020) 'Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells', International Journal of Molecular Sciences, 21(8), pp. 2997. doi:10.3390/ijms21082997 Preclinical
https://doi.org/10.3390/ijms21082997 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Bryson, P.D. and Watanabe, A.S. and Rumack, B.H. and Murphy, R.C (1978) 'Burdock root tea poisoning. Case report involving a commercial preparation', JAMA, 239(20), pp. 2157. Available at: https://pubmed.ncbi.nlm.nih.gov/642161/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/642161/ - Berdai, M.A. and Labib, S. and Chetouani, K. and Harandou, M (2012) 'Atropa belladonna intoxication: a case report', Pan African Medical Journal, 11, pp. 72. Available at: https://pubmed.ncbi.nlm.nih.gov/22655106/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22655106/ - Oerlemans, C. and de Vries, I. and van Riel, A.J.H.P (2017) 'Anticholinergic syndrome caused by contaminated herbal tea; acting swiftly to identify the source', Nederlands Tijdschrift voor Geneeskunde, 161, pp. D1261. Available at: https://pubmed.ncbi.nlm.nih.gov/28612694/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/28612694/
- Kim, S.K., Jung, J., Jung, J.H., Yoon, N. and others (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800 Meta-analysis / review
https://doi.org/10.2174/1389203719666180622095800 - Raina, K., Kumar, D. and Agarwal, R (2016) 'Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy', Seminars in Cancer Biology, 40-41, pp. 116-129. doi:10.1016/j.semcancer.2016.07.002 Meta-analysis / review
https://doi.org/10.1016/j.semcancer.2016.07.002 - Basch, E., Gabardi, S. and Ulbricht, C (2003) 'Bitter melon (Momordica charantia): a review of efficacy and safety', American Journal of Health-System Pharmacy, 60(4), pp. 356-359. doi:10.1093/ajhp/60.4.356 Meta-analysis / review
https://doi.org/10.1093/ajhp/60.4.356 - Bora, A.F.M., Kouame, K.J.E., Li, X., Liu, L. and others (2023) 'New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review', International Journal of Biological Macromolecules, 231, pp. 123173. doi:10.1016/j.ijbiomac.2023.123173 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2023.123173 - Soo May, L., Sanip, Z., Ahmed Shokri, A., Abdul Kadir, A. and others (2018) 'The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial', Complementary Therapies in Clinical Practice, 32, pp. 181-186. doi:10.1016/j.ctcp.2018.06.012 Randomized trial
https://doi.org/10.1016/j.ctcp.2018.06.012 - Elekofehinti, O.O., Ariyo, E.O., Akinjiyan, M.O., Olayeriju, O.S. and others (2018) 'Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies', Pathophysiology, 25(4), pp. 327-333. doi:10.1016/j.pathophys.2018.05.003 Preclinical
https://doi.org/10.1016/j.pathophys.2018.05.003 - Leung, L., Birtwhistle, R., Kotecha, J., Hannah, S. and others (2009) 'Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review', British Journal of Nutrition, 102(12), pp. 1703-1708. doi:10.1017/S0007114509992054 Meta-analysis / review
https://doi.org/10.1017/S0007114509992054 - Krawinkel, M.B. and Keding, G.B (2006) 'Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia', Nutrition Reviews, 64(7 Pt 1), pp. 331-337. doi:10.1301/nr.2006.jul.331-337 Meta-analysis / review
https://doi.org/10.1301/nr.2006.jul.331-337 - Fang, E.F. and Ng, T.B (2011) 'Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties', Current Molecular Medicine, 11(5), pp. 417-436. doi:10.2174/156652411795976583 Meta-analysis / review
https://doi.org/10.2174/156652411795976583 - Cicek, S.S (2022) 'Momordica charantia L. - Diabetes-Related Bioactivities, Quality Control, and Safety Considerations', Frontiers in Pharmacology. doi:10.3389/fphar.2022.904643 Traditional / reference
https://doi.org/10.3389/fphar.2022.904643 - WebMD (n.d.) 'Bitter Melon: Overview, Uses, Side Effects, Precautions, Interactions'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon - Yedjou, C.G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L. and Tchounwou, P.B (2023) 'The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins', International Journal of Molecular Sciences. doi:10.3390/ijms24109085 Randomized trial
https://doi.org/10.3390/ijms24109085 - Kim, S.K., Jung, J., Jung, J.H., Yoon, N., Kang, S.S., Roh, G.S. and Hahm, J.R (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.